Sol-Gel Technologies Ltd. (SLGL) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Sol-Gel Technologies Ltd. (SLGL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $215.6M, listed on NASDAQ, employing roughly 34 people, carrying a beta of 1.17 to the broader market. Sol-Gel Technologies Ltd. Led by Moshe Arkin, public since 2018-02-01.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for SLGL as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →